4//SEC Filing
Ciechanover Isaac E. 4
Accession 0001209191-19-030024
CIK 0001604464other
Filed
May 14, 8:00 PM ET
Accepted
May 15, 4:35 PM ET
Size
10.3 KB
Accession
0001209191-19-030024
Insider Transaction Report
Form 4
Ciechanover Isaac E.
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2019-05-13$24.23/sh−3,500$84,805→ 300,837 total(indirect: See footnote) - Sale
Common Stock
2019-05-13$24.95/sh−400$9,980→ 300,437 total(indirect: See footnote) - Sale
Common Stock
2019-05-14$24.92/sh−3,900$97,188→ 296,537 total(indirect: See footnote)
Holdings
- 332,243
Common Stock
Footnotes (5)
- [F1]Transaction pursuant to Rule 10b5-1 Plan adopted January 23, 2018.
- [F2]The price in Column 4 is a weighted average sale price. The prices actually received ranged from $23.75 to $24.62. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]Shares are held by the Isaac E. Ciechanover and Allison M. Ciechanover Family Trust dated 8/8/08, of which the Reporting Person is a trustee.
- [F4]The price in Column 4 is a weighted average sale price. The prices actually received ranged from $24.91 to $25.05. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F5]The price in Column 4 is a weighted average sale price. The prices actually received ranged from $24.51 to $25.08. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Documents
Issuer
Atara Biotherapeutics, Inc.
CIK 0001604464
Entity typeother
Related Parties
1- filerCIK 0001612096
Filing Metadata
- Form type
- 4
- Filed
- May 14, 8:00 PM ET
- Accepted
- May 15, 4:35 PM ET
- Size
- 10.3 KB